Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Molecules. 2021 Dec 16;26(24):7643. doi: 10.3390/molecules26247643.
Molecules. 2021.
PMID: 34946726
Free PMC article.
BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis.
Gómez-Almería M, Burgaz S, Costas-Insua C, Rodríguez-Cueto C, Santos-García I, Rodríguez-Crespo I, García C, Guzmán M, de Lago E, Fernández-Ruiz J.
Gómez-Almería M, et al. Among authors: burgaz s.
Int J Mol Sci. 2021 Nov 20;22(22):12533. doi: 10.3390/ijms222212533.
Int J Mol Sci. 2021.
PMID: 34830414
Free PMC article.
Item in Clipboard
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.
Burgaz S, García C, Gómez-Cañas M, Rolland A, Muñoz E, Fernández-Ruiz J.
Burgaz S, et al.
Molecules. 2021 May 28;26(11):3245. doi: 10.3390/molecules26113245.
Molecules. 2021.
PMID: 34071302
Free PMC article.
Item in Clipboard
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.
Burgaz S, García C, Gómez-Cañas M, Navarrete C, García-Martín A, Rolland A, Del Río C, Casarejos MJ, Muñoz E, Gonzalo-Consuegra C, Muñoz E, Fernández-Ruiz J.
Burgaz S, et al.
Mol Cell Neurosci. 2021 Jan;110:103583. doi: 10.1016/j.mcn.2020.103583. Epub 2020 Dec 16.
Mol Cell Neurosci. 2021.
PMID: 33338634
Item in Clipboard
Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease.
Espadas I, Keifman E, Palomo-Garo C, Burgaz S, García C, Fernández-Ruiz J, Moratalla R.
Espadas I, et al. Among authors: burgaz s.
Neurobiol Dis. 2020 Jul;141:104892. doi: 10.1016/j.nbd.2020.104892. Epub 2020 May 6.
Neurobiol Dis. 2020.
PMID: 32387338
Free article.
Item in Clipboard
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.
Burgaz S, García C, Gómez-Cañas M, Muñoz E, Fernández-Ruiz J.
Burgaz S, et al.
Molecules. 2019 Jul 25;24(15):2702. doi: 10.3390/molecules24152702.
Molecules. 2019.
PMID: 31349553
Free PMC article.
Item in Clipboard
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C, Gómez-Cañas M, Burgaz S, Palomares B, Gómez-Gálvez Y, Palomo-Garo C, Campo S, Ferrer-Hernández J, Pavicic C, Navarrete C, Luz Bellido M, García-Arencibia M, Ruth Pazos M, Muñoz E, Fernández-Ruiz J.
García C, et al. Among authors: burgaz s.
J Neuroinflammation. 2018 Jan 16;15(1):19. doi: 10.1186/s12974-018-1060-5.
J Neuroinflammation. 2018.
PMID: 29338785
Free PMC article.
Item in Clipboard
Cite
Cite